BIOMAT Database Logo BIOMAT Database Logo

Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. 1995

K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
Division of Hematology, University of Washington, Seattle 98195, USA.

Thrombopoietin (TPO), the ligand for the receptor protooncogene c-mpl, has been cloned and shown to be the critical regulator of platelet production. Several features of c-Mpl expression, including its presence on erythroid cell lines, and the panmyeloid transformation characteristic of myeloproliferative leukemia (MPL) viral disease led us to investigate whether this receptor-ligand system may play a role in erythropoiesis. We report that although TPO alone did not support the growth of either early or late erythroid progenitors, it acted in synergy with erythropoietin to expand these populations. Moreover, while the effects on erythropoiesis in normal animals were modest, TPO greatly expanded the number of erythroid progenitors and blood reticulocytes and was associated with accelerated red cell recovery in myelosuppressed mice. Together, these data strongly suggest that erythroid progenitors respond to TOP and that this newly cloned cytokine, critical for platelet production, can augment erythropoiesis in states of marrow failure.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay

Related Publications

K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors.
October 1995, Blood,
K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
Thrombopoietin enhances proliferation and differentiation of murine yolk sac erythroid progenitors.
February 1997, Blood,
K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
[Immortalization of erythroid progenitors for in vitro large-scale red cell production].
September 2017, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
Sox6 enhances erythroid differentiation in human erythroid progenitors.
March 2011, Blood,
K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy.
June 2015, Journal of hematology & oncology,
K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
Thrombopoietin expands hematopoietic stem cells after transplantation.
August 2002, The Journal of clinical investigation,
K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells.
June 2015, The Journal of clinical investigation,
K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
The effect of thrombopoietin on erythroid progenitors in Diamond-Blackfan anemia.
May 2002, International journal of hematology,
K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
Platelet production rate in polycythemia vera after myelosuppressive therapy.
September 1972, Acta medica Scandinavica,
K Kaushansky, and V C Broudy, and A Grossmann, and J Humes, and N Lin, and H P Ren, and M C Bailey, and T Papayannopoulou, and J W Forstrom, and K H Sprugel
TGF-β inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors.
December 2016, Blood,
Copied contents to your clipboard!